Three robotics experts at MD&M West looked at the iterative process of developing medical robotic tools and discussed valuable takeaways from watching the industry leader, Intuitive Surgical, rise to the top.
R&D - Industry Insight
Victor Gura, MD, inventor of the Wearable Artificial Kidney, spoke at MD&M West about design considerations, obstacles, and goals involved with developing a portable dialysis device.
A design engineer speaking at MD&M Minneapolis demonstrates how virtual reality technology can play a meaningful role in product development.
An R&D expert will share tips for getting a product to market quickly without letting project stress drive a wedge between you and your co-workers.
Industry professional says that overlooking user research in product design could lead to some missed opportunities and dire consequences.
Is it possible for established medical device companies to drastically reduce their time to market by cutting back on QMS documentation, while still meeting FDA requirements?
Find out how a design firm took a large-scale medical imaging project from sketch to commercial product within one year using the Microsoft HoloLens for rapid prototyping.
Why do medical device developers need to stay ahead of the curve on trendy technologies like augmented reality and virtual reality? In this Facebook Live video, an expert from Worrell talks about applying technologies like AR and VR to the medical device world.
An industry expert discusses the importance of marrying research and development with your company’s broader business strategy to achieve viable projects.
An R&D professional with tricks up his sleeve showed MD&M West attendees how to apply the art of magical illusion to their next product development project.
Embracing connected technologies and artificial intelligence can help medtech achieve the goals of value-based and consumer-driven care. Still skeptical? Consider this example.
Bill Gates told attendees at the J.P. Morgan Healthcare Conference that, while competition can be beneficial to medical research progress, he doesn't really consider biomedical research funding a competition between the United States and other countries.
Disease risk scores are being furthered by machine learning algorithms, including a new risk score developed by IBM Research.